123 related articles for article (PubMed ID: 36788478)
1. Timing of ocular examination and retinal imaging for the diagnosis of type 2 macular telangiectasia (MacTel).
Sharief S; Venkatesh R; Mangla R; Chhablani J
Eur J Ophthalmol; 2023 Nov; 33(6):NP79-NP81. PubMed ID: 36788478
[TBL] [Abstract][Full Text] [Related]
2. Epiretinal membrane formation and optic disc vascularisation in type 2A macular telangiectasia (MacTel).
Venkatesh R; Mangla R; Handa A; Parmar Y; Sangoram R; Chhablani J
Eur J Ophthalmol; 2024 Mar; 34(2):NP78-NP82. PubMed ID: 37644815
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
4. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
5. Different types of macular telangiectasia in two eyes of a patient.
Venkatesh R; Reddy NG; Pereira A; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Sep; 32(5):NP9-NP12. PubMed ID: 33960244
[TBL] [Abstract][Full Text] [Related]
6. Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2.
Chandran K; Desai S; Giridhar A
Oman J Ophthalmol; 2023; 16(2):377-381. PubMed ID: 37602186
[TBL] [Abstract][Full Text] [Related]
7. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
8. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
9. Retinal crystals in type 2 idiopathic macular telangiectasia.
Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
[TBL] [Abstract][Full Text] [Related]
10. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
12. Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study - Report No. 2.
Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
Ophthalmic Epidemiol; 2021 Oct; 28(5):436-443. PubMed ID: 33459094
[No Abstract] [Full Text] [Related]
13. Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.
Chew EY; Peto T; Clemons TE; Sallo FB; Pauleikhoff D; Leung I; Jaffe GJ; Heeren TFC; Egan CA; Charbel Issa P; Balaskas K; Holz FG; Gaudric A; Bird AC; Friedlander M
Ophthalmol Sci; 2023 Jun; 3(2):100261. PubMed ID: 36846105
[TBL] [Abstract][Full Text] [Related]
14. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia.
Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
Eye (Lond); 2022 Aug; 36(8):1623-1630. PubMed ID: 34326496
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia.
Venkatesh R; Pereira A; Bavaharan B; Jain K; Aseem A; Sangai S; Yadav NK
J Curr Ophthalmol; 2020; 32(4):375-380. PubMed ID: 33553840
[TBL] [Abstract][Full Text] [Related]
16. Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique: Case reports.
Nishiyama S; Iwase T
Medicine (Baltimore); 2021 Sep; 100(36):e27078. PubMed ID: 34516496
[TBL] [Abstract][Full Text] [Related]
17. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
Dogan B; Erol MK; Akidan M; Suren E; Akar Y
Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862
[TBL] [Abstract][Full Text] [Related]
18. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
19. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
Park YG; Park YH
PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
